abstract |
The present invention relates to a novel anti-cancer composition, and more specifically to an anti-cancer composition containing the compound of Formula 1 or a derivative thereof as an active ingredient. The compounds of the present invention are effective in preventing and treating cancers that effectively induce the death of cancer cells by inhibiting the activity of AIMP2-DX2, a new anticancer drug target. Therefore, the compounds of the present invention can be used for the purpose of preventing and treating cancer diseases. |